WAS and Wiskott-Aldrich syndrome: To address the safety issues with γ-retroviral vectors for Wiskott-Aldrich syndrome, we developed a self-inactivating lentiviral vector encoding human WASP under the control of a 1·6 kb reconstituted WAS gene promoter.12